Business
Advantis Corp. Appoints Chief Medical Director to Develop CBD Based Nutraceuticals
Advantis Corp. Appoints Chief Medical Director to Develop CBD Based Nutraceuticals.
About this update from Advantis Corporation
[{"type":"text","content":"\n \n \n Advantis Corp. Appoints Chief Medical Director to Develop CBD Based Nutraceuticals\n \n \nAdvantis Corp. Appoints Chief Medical Director to Develop CBD Based Nutraceuticals\n \n SANTA ANA, CA--(Marketwired - May 3, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced it has hired Thomas Elgin, MD, as its Chief Medic. Dr. Elgin has worked in emergency medicine for fifteen years, and has extensive experience researching and developing nutraceuticals. CBD based nutraceuticals is the fastest growing sector within the medical marijuana business. \"There have been numerous studies documenting significant benefits from the use of medical cannabis,\" Elgin commented, \"I am excited to begin the thorough testing and development of CBD related compounds that will finally provide a non-addictive source of relief.\" Medical cannabis has been shown to provide tangible benefits for those suffering from cancer, PTSD, anxiety, and chronic pain. \"Chronic Pain visits to the ER are on the rise, and a marked increase in addiction to prescription opiates has been the result,\" Elgin said. \"We need a new approach to tackle this problem, because the current approach is simply not working. I believe CBD compounds are the answer.\" \n Advantis CEO, Christopher Swartz says that Dr. Elgin will additionally be responsible for testing the efficacy of products Advantis acquires and distributes. Swartz shares the doctor's excitement about the future of CBD technology. \"I am passionate about finding effective solutions to cure this chronic pain epidemic,\" Swartz stated. \"Dr. Elgin has been working with me at Sequence Therapy to develop proper exercises, and now at Advantis we will work together to develop effective medicines.\" Advantis has been working with medical marijuana provider, Natural Elements, who will be providing the CBD materials for research and development of nutraceutical products that can be used used orally (including its infusion into food and beverage products), topically, or through inhalation. \"I am excited that Dr. Elgin shares my passion for providing for millions of people suffering from chronic pain,\" Swartz said. \"Together, with Natural Elements, and Sequence Therapy, Advantis will make giant steps toward bringing a revolutionary pain relief process to those in need.\" \n Swartz also mentioned that the search for ...